Ahmad Hashash

Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors.

Abran Q. Costales, S. Ramurthy, S. Subramanian, 2011, Bioorganic & medicinal chemistry letters.

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

S. Leavitt, T. Appleby, M. Fenaux, 2012, Antimicrobial Agents and Chemotherapy.

Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.

S. Leavitt, T. Appleby, M. Fenaux, 2014, Journal of medicinal chemistry.

Water-soluble prodrugs of an Aurora kinase inhibitor.

Amy D. Fung, R. Mcdowell, J. Jacobs, 2009, Bioorganic & medicinal chemistry letters.

Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

Z. Ni, D. Tyrrell, A. Weiner, 2006, Hepatology.

Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats

R. Gibbs, David A. Johnson, Ahmad Hashash, 1997, Brain Research.

Solubility, ionization, and partitioning behavior of unsymmetrical disulfide compounds: alkyl 2-imidazolyl disulfides.

J. Lazo, D. Kirkpatrick, L. Block, 2002, Journal of pharmaceutical sciences.

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

R. Fucini, A. Howlett, Brian J. Belmont, 2010, Cancer Chemotherapy and Pharmacology.

Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.

T. Appleby, M. Fenaux, Xiaowu Chen, 2014, Journal of medicinal chemistry.